PIK3C2G

Across TCGA pan-cancer cohorts, PIK3C2G mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of PIK3C2G’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where PIK3C2G mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types PIK3C2G is over-expressed in tumor, although a few such as CCRCC and LUAD show the opposite, repressed pattern.

CCRCC and LUAD are the cancer types where PIK3C2G tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PIK3C2G mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	All	IV	−0.577	.023	5	view →
LUAD	All	All	−1.322	<.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

PIK3C2G–CCRCC

Open the CCRCC breakdown →